S&C Partners Frank Aquila and Matt Hurd Named Among Top 10 Healthcare Lawyers in North America

March 12, 2020

S&C global head of M&A Frank Aquila and Matt Hurd, co-head of S&C’s Healthcare & Life Sciences Group, were both named to Mergerlinks’ list of the Top 10 healthcare lawyers in North America. They are recognized for working on approximately $23.2 billion and $26.1 billion worth of deals, respectively, in 2019. Among the significant healthcare deals Frank and Matt advised on were Novartis’ $9.7 billion acquisition of The Medicines Company and Amgen’s $13.4 billion acquisition of the worldwide rights to Otezla®.